Medicare Enrolled

Dr. Chaim Bernstein, M.D.

Pulmonary Disease · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2000 OCEAN AVE, Brooklyn, NY 11230
7186761028
In practice since 2005 (20 years)
NPI: 1548262348 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bernstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bernstein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bernstein

Dr. Chaim Bernstein is a pulmonary disease specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bernstein performed 1,713 Medicare services across 739 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bernstein received a total of $221,630 from 36 pharmaceutical and/or device companies across 949 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bernstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 24% volume in NY $221,630 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,713
Medicare services
Top 24% in NY for pulmonary disease
739
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~86 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
547 $102 $152
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
497 $17 $23
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
353 $36 $49
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
163 $30 $30
New patient office visit, complex (60-74 min) 81 $189 $270
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
26 $32 $43
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
17 $61 $65
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
17 $30 $30
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
12 $26 $38
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$221,630
Total received (2018-2024)
Avg $31,661/year across 7 years
Top 3% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
949
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$201,379 (90.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,422 (5.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,830 (3.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$12,737
2023
$13,446
2022
$28,290
2021
$26,832
2020
$32,252
2019
$58,947
2018
$49,126

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$10,176
Baxter Healthcare
$965
AstraZeneca Pharmaceuticals LP
$778
Medtronic, Inc.
$355
GlaxoSmithKline, LLC.
$186
Mylan Specialty L.P.
$80
Regeneron Healthcare Solutions, Inc.
$70
Amgen Inc.
$63
Philips North America LLC
$24
Mallinckrodt Hospital Products Inc.
$18
Paratek Pharmaceuticals, Inc.
$14
3B Medical, Inc.
$8
Top 3 companies account for 93.6% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$89,777
Mallinckrodt Hospital Products Inc.
$44,314
Sunovion Pharmaceuticals Inc.
$37,799
Insmed, Inc.
$13,372
Mallinckrodt LLC
$13,038
Mallinckrodt Enterprises LLC
$7,316
GlaxoSmithKline, LLC.
$4,585
AstraZeneca Pharmaceuticals LP
$3,103
Baxter Healthcare
$2,043
Philips Electronics North America Corporation
$1,861
Advanced Respiratory, Inc
$896
Mylan Specialty L.P.
$662
Regeneron Healthcare Solutions, Inc.
$497
Medtronic, Inc.
$355
Regeneron Pharmaceuticals, Inc.
$268
ADVANCED RESPIRATORY, INC
$267
GENZYME CORPORATION
$260
Electromed, Inc.
$193
Amgen Inc.
$192
Actelion Pharmaceuticals US, Inc.
$179
BIOTRONIK INC.
$126
Teva Pharmaceuticals USA, Inc.
$94
Genentech USA, Inc.
$93
Abbott Laboratories
$75
Grifols USA, LLC
$63
Circassia Pharmaceuticals Inc
$39
Philips North America LLC
$24
Novartis Pharmaceuticals Corporation
$20
Kowa Pharmaceuticals America, Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
ANI Pharmaceuticals, Inc.
$16
Novo Nordisk Inc
$16
Merck Sharp & Dohme LLC
$15
Paratek Pharmaceuticals, Inc.
$14
United Therapeutics Corporation
$14
3B Medical, Inc.
$8
Top 3 companies account for 77.6% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · ARALAST · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ENDURANT IIS · Esbriet · FARXIGA · FASENRA · Hillrom - Vest System Model 105 Home Care · LONHALA MAGNAIR · LUNA · Life 2000 Ventilation System · Livalo · NUCALA · NUZYRA · OFEV · OPSUMIT · PURIFIED CORTROPHIN GEL · Pacemakers · Perforomist · Prolastin-C · Prolastin-C Liquid · RYBELSUS · Respiratoriy Care Undiv · SEEBRI · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Trilogy 100 · UPTRAVI · UTIBRON · UTIBRON NEOHALER · Utibron · Wellcentive Undiv · XOLAIR · Xofluza · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for pulmonary disease in NY.

Looking for a pulmonary disease specialist in Brooklyn?
Compare pulmonary diseases in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
628
Per 100K population
23.7
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bernstein is a clinical cardiology specialist, with above-average Medicare volume (top 24% in NY), with speaking/promotional industry engagement in the top 3% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bernstein experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bernstein performed 547 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bernstein receive payments from pharmaceutical companies?
Yes. Dr. Bernstein received a total of $221,630 from 36 companies across 949 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bernstein's costs compare to other pulmonary diseases in Brooklyn?
Dr. Bernstein's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bernstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →